Professional background
She advises various companies in the healthcare and life sciences sectors, such as pharmaceutical companies, medical device manufacturers and biocide manufacturers, on regulatory issues. She also acts in litigation.
Alice is member of the Paris Bar since 2022. She graduated from the University of Paris V with a Master degree (I) in Health law and a Master degree (II) in Health Products Industry Law.
Prior to joining Fieldfisher, she worked as paralegal and then as a lawyer at Dentons AARPI in the Life Sciences Regulatory department. she did internships at Choisez et Associés and at Laboratoires Servier as a Pharmaceutical Affairs Manager.
She speaks French and English.
Authored pieces
Life Sciences
Insight
LFSS 2026: What the new Supplementary Contribution means for Pharma
10.03.2026
France’s Social Security Financing Act for 2026 (LFSS 2026) introduces a change that reshapes how pharmaceutical companies manage their financial exposure. At the centre of the reform is a new 'Supplementary Contribution' on turnover (alongside the basic and additional turnover contributions), which is a measure designed to bring more clarity to a system that, for years, has been criticised as unpredictable and increasingly unmanageable.
Lawyers I've worked with
